0000921895-24-000809.txt : 20240405 0000921895-24-000809.hdr.sgml : 20240405 20240405101405 ACCESSION NUMBER: 0000921895-24-000809 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mokhtar Firdauz CENTRAL INDEX KEY: 0001861217 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 24825061 MAIL ADDRESS: STREET 1: TRIDENT COURT, 1 OAKCROFT ROAD STREET 2: CHESSINGTON CITY: SURREY STATE: X0 ZIP: KT9 1BD ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 3 1 form313531001mok_04052024.xml OWNERSHIP DOCUMENT X0206 3 2024-04-02 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001861217 Mokhtar Firdauz TRIDENT COURT, 1 OAKCROFT ROAD CHESSINGTON SURREY X0 KT9 1BD UNITED KINGDOM 1 0 0 0 Common Stock 0 D No securities are beneficially owned. /s/ Firdauz Edmin Bin Mokhtar 2024-04-05